Abstract
BackgroundEnhanced S-cone syndrome is an autosomal recessive retinal dystrophy related to a defect in a nuclear receptor gene (NR2E3) that leads to alteration in cells development from rod to S-cone. This retinal dystrophy may be associated with retinal schisis. The aim of this report is to describe structural optical coherence tomography and optical coherence tomography angiography features in a case of enhanced S-cone syndrome associated with macular schisis.Case presentationA Caucasian 13-year-old girl underwent measurement of best corrected visual acuity, ophthalmoscopic evaluation, and fundus autofluorescence examination. Photopic and scotopic electroretinography were carried out as well. Enhanced S-cone syndrome was suspected on the basis of clinical and electrophysiological findings. Structural optical coherence tomography and optical coherence tomography angiography allowed the further characterization of the associated macular schisis.Genetic analysis not only confirmed the diagnosis but increased the clinical novelty of this case report by showing two variations in the NR2E3 gene probably related to the phenotype: a missense variation c.1118T>C which leads to the substitution of leucine with proline in amino acid position 373, and c.349+5G>C, which involves a gene sequence near a splicing site.ConclusionsSwept source structural optical coherence tomography (B scans and “en face” images) and optical coherence tomography angiography allowed the observation of retinal structural details and the involvement of each retinal layer and capillary plexus in enhanced S-cone syndrome. Of interest, neither of the two NR2E3 gene variants found in this case report have been linked to any form of retinopathy.
Highlights
Enhanced sensitive cones (S-cones) syndrome is an autosomal recessive retinal dystrophy related to a defect in a nuclear receptor gene (NR2E3) that leads to alteration in cells development from rod to S-cone
Swept source structural optical coherence tomography (B scans and “en face” images) and optical coherence tomography angiography allowed the observation of retinal structural details and the involvement of each retinal layer and capillary plexus in enhanced S-cone syndrome
Neither of the two NR2E3 gene variants found in this case report have been linked to any form of retinopathy
Summary
Enhanced S-cone syndrome is an autosomal recessive retinal dystrophy related to a defect in a nuclear receptor gene (NR2E3) that leads to alteration in cells development from rod to S-cone. Enhanced S-cone syndrome (ESCS) is an autosomal recessive retinal dystrophy which was first described in 1990 as clinically characterized by night blindness and a nummular pigmentary deposit in the retinal pigment epithelium outside the vascular arcades [1] These features could be Genetically, ESCS is related to a defect in the nuclear receptor subfamily 2 group E member 3 gene (NR2E3) which encodes a rod-specific ligand-dependent transcription factor that plays a key role in the differentiation of post-mitotic photoreceptor precursor cells [5,6,7,8]. Minnella et al Journal of Medical Case Reports (2018) 12:287 eye showed a degenerative retina with no rods and an abnormal increase in the number of cones, mostly S-cones [9] These retinal findings are consistent with the peculiar response on electroretinography (ERG) which reveals enhanced short-wavelength sensitivity and absent rod function. A 30 Hz flicker is markedly delayed with an amplitude lower than normal and a cone b-wave loss greater than that of the photopic a-wave [2]
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.